Press release
Japanese Encephalitis Therapeutics - Pipeline Analysis, Clinical Trials, Patent and Collaborations
Explore report sample at: https://www.psmarketresearch.com/market-analysis/japanese-encephalitis-therapeutics-pipeline/report-sample
The companies developing drugs for the treatment of Japanese encephalitis are laying more emphasis on the drug candidates to be developed as vaccines, due to the promising results shown by these candidates the in the clinical development. Based on molecule type, around 75.0% of the therapeutic candidates are being developed as vaccines, around 13.0% are made as peptide and 12.0% are being developed as small molecule.
In September 2017, VABIOTECH in collaboration with National Institute of Hygiene and Epidemiology (NIHE), Vietnam, initiated a Phase III, randomized, multi-centered, parallel groups assignment trial to assess the immunogenicity and safety of the JECEVAX in healthy male as well as female children of age between nine to 24 months.
Browse report at: https://www.psmarketresearch.com/market-analysis/japanese-encephalitis-therapeutics-pipeline
Some of the key players developing drugs for the treatment of Japanese encephalitis include Shandong Hengye Biotech, Co. Ltd., Panacea Biotec Ltd., and Ennaid Therapeutics, LLC.
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Japanese Encephalitis Therapeutics - Pipeline Analysis, Clinical Trials, Patent and Collaborations here
News-ID: 1264002 • Views: …
More Releases from P&S Intelligence - Pharmaceuticals
Cyclin-Dependent Kinase Inhibitors Therapeutics Key Players Analysis - Merck, El …
The study analyzed that the CDK inhibitors therapeutics pipeline comprises approximately 24 drug candidates in different stages of development.
CDKs are the catalytic subunits of serine or threonine protein kinases that regulate the checkpoints in the cell cycle to control the proliferative capacity of cancerous cells. These proteins form cyclin-CDK complex which gets activated after phosphorylation, leading to cell proliferation.
Download report sample at: http://bit.ly/2eqiPu5
**Various collaborations for CDK inhibitors drug development
Eli Lilly…
Systemic Lupus Erythematosus Pipeline Analysis - Anthera Pharmaceuticals, Inc., …
The study analyzed that the systemic lupus erythematosus pipeline comprises of 57 drug candidates in different stages of development.
Explore report sample at: https://www.psmarketresearch.com/market-analysis/systemic-lupus-erythematosus-pipeline-analysis/report-sample
Systemic lupus erythematosus is a type of lupus in which the immune system damages its own tissues. The disease affects many parts of the body including skin, joints, lungs, brain, blood vessels and kidneys. The systemic lupus erythematosus is caused by impaired immune system due to which the…
Herpes Simplex Virus Infections Therapeutic - Pipeline Analysis, Clinical Trials …
The study analysed that the Herpes simplex virus infections pipeline comprises of 20 drug candidates in different stages of development.
As per the findings of the research, most of the drug candidates are being developed to be administered by oral route.
Explore report sample at: https://www.psmarketresearch.com/market-analysis/hsv-infections-therapeutics-pipeline-analysis/report-sample
Many technologies are being developed that offer promising innovative treatments which can control the progression of Herpes simplex virus infections. The technologies include, but not limited to,…
mTOR Inhibitors Therapeutics Pipeline - Analysis, Clinical Trials, Collaboration …
According to the research findings, most of the drug candidates that act as mTOR inhibitors are being developed as small molecules, further supported by the fact that small molecules have several advantages such as it can be manufactured with production rate higher than any other molecule types.
Explore report sample at: https://www.psmarketresearch.com/market-analysis/mtor-inhibitors-therapeutics/report-sample
The positive clinical results of mTOR inhibitors drug candidates is a key factor driving the pipeline growth. For instance, F.…
More Releases for Japanese
JE (Japanese Encephalitis) Vaccine Market
The global JE (Japanese encephalitis) vaccine market was estimated to value at USD 215.15 million in 2023. It is expected to grow at a CAGR of 5.5% during the forecast period of 2024-2032, reaching a value of USD 348.34 million in 2032. Japanese encephalitis (JE) is a viral infection spread by mosquitoes, primarily affecting regions of Asia and the Western Pacific. It is the leading cause of viral encephalitis in…
[Unlimited lessons] Unlimited Japanese Lessons with Native Teachers for $60/Mont …
Dialogplus Group Co., Ltd. launched a new plan at JPLT Online Japanese School, where you can take unlimited Japanese lessons with native teachers for only $60 per month.
In addition to standard courses such as the Japanese Language Proficiency Test (JLPT) course and daily English conversation course, you can enjoy unlimited original and unique classes taught by native Japanese teachers.
JPLT is the world's largest metaverse Japanese school, providing a free online…
How Does Japanese Knotweed Spread?
Japanese knotweed is a fast-growing invasive weed that is feared by UK landowners due to the impact it can have on property values and the damage it can cause if left untreated.
Unlike most plants, Japanese knotweed doesn't spread via the seeds. While it does produce seeds, they don't germinate - instead, it's the stem, rhizome and crown that enable the weed to spread.
Let's take a closer look at how this…
Top-grossing Japanese Mobile Game, “Logres: Japanese RPG” launches Beta Test …
Tokyo, Japan – April 6, 2017 – Marvelous Inc. and Aiming Inc. launches the Beta test of the English version of its top-grossing MMORPG title in Japan, Logres: Japanese RPG.
An epic online multiplayer game featuring anime-style graphics and downloaded by millions after its launch in Japan, the Beta test of the English version will be open to Android users in United States, Canada, Australia, United Kingdom, and New Zealand…
Japanese secret to longevity
It is slowly reaching the season of autumn, where temperature difference between night and day is clearly noticeable. This may cause vasoconstriction which may lead to cardiovascular diseases. According to a British research, cardiovascular diseases have a 25% higher percentage of occurring in autumn than in any other seasons. Low temperature may cause instability in the blood vessels, high blood pressure, poor blood circulation and other physiological changes. Coupled with…
Cutting Off Japanese ODA
To make recovery for economy and infrastructure, Japan has to decrease official development assistance (ODA) for other countries.
Due to the effect of earthquake and tsunami, Japan has faced with serious problem of both material and human. Although the country has received aid from all over the world, Japan needs more to recover injury by the disaster.
On April 22nd , the Japanese government passed the first supplementary budget about 4,000…
